Trial Profile
evaluation of epinastine hydrochloride ophthalmic solution in allergic conjunctivitis by conjunctival white birch pollen allergen challenge double masked, comparison study
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 12 May 2016
Price :
$35
*
At a glance
- Drugs Epinastine (Primary)
- Indications Allergic conjunctivitis
- Focus Therapeutic Use
- 25 Aug 2015 Status changed from not yet recruiting to completed as per University Hospital Medical Information Network - Japan.
- 04 Dec 2014 New trial record